Myron Czuczman - 10 Oct 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTXR	Stock Option (Right to Purchase Common Stock)	Award	$0	+300,000	$0.000000	300,000	10 Oct 2023	Common Stock	300,000	$0.7000	Direct	F1
holding	CTXR	Stock Option (Right to Purchase Common Stock)					300,000	10 Oct 2023	Common Stock	300,000	$1.25	Direct	F2
holding	CTXR	Stock Option (Right to Purchase Common Stock)					300,000	10 Oct 2023	Common Stock	300,000	$2.04	Direct	F3
holding	CTXR	Stock Option (Right to Purchase Common Stock)					500,000	10 Oct 2023	Common Stock	500,000	$1.19	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2	The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F3	The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F4	The options vested on July 14, 2022.